• PDF / 136,335 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 88 Downloads / 205 Views

DOWNLOAD

REPORT

1

■ The UK’s MHRA has ruled that products containing 1,3-dimethylamylamine (DMAA) must be removed from the UK market on the basis of potential safety issues.* DMAA has been linked to several ADRs worldwide, including at least one fatality. The MHRA ruled that the popular sports supplement Jack3D is an unlicensed medicinal product, but all DMAAcontaining supplements must be removed. "People need to be aware when choosing their sports supplements. These products may claim to increase performance but contain powerful ingredients which can have serious side effects" said David Carter, Manager of the MHRA’s Medicines Borderline Section. * See also Reactions 1415 p4; 803075269 The Medicines and Healthcare Products Regulatory Agency. MHRA to remove popular sports supplement used by international athletes from the market Media Release : 28 Aug 2012. Available from: URL: http:// 809140667 www.mhra.gov.uk

0114-9954/10/1418-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Reactions 8 Sep 2012 No. 1418

Recommend Documents

Investing in Fundamental Research: Evaluation of the Benefits that the UK Has Derived from CERN

156 36 4MB

The UK Department of Health has agreed, in principle, with the JCVI's* recommendations that HPV** vaccines should be rou

149 17 133KB

GSK UK has written to health care professionals to highlight that the rotavirus vaccine [Rotarix] should be administered

150 12 133KB

UK NIBSC to merge with MHRA

154 35 117KB

Macroprudential Policy and the UK Housing Market

169 18 3MB

HAS to be NICE?

174 28 114KB

"The electrification of heavy-duty traffic must be actively promoted"

147 23 397KB

You Must Be Very Intelligent The PhD Delusion

145 64 7MB

Gold standard must be solid gold

179 65 190KB

Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devas

127 83 539KB

The MHRA has advised healthcare professionals about the risk of acute pancreatitis associated with DPP-IV inhibitors (gl

143 100 133KB

How much do consumers know about the quality of products? Evidence from the diaper market

180 47 861KB